22 results on '"Tarnow L"'
Search Results
2. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial
3. Low-dose spironolactone reduces plasma fibulin-1 levels in patients with type 2 diabetes and resistant hypertension
4. ACTH stimulation test in patients with type 1 diabetes and recurrent severe hypoglycaemia
5. At least one in three people with Type 2 diabetes mellitus referred to a diabetes centre has symptomatic obstructive sleep apnoea
6. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
7. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes
8. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy
9. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril
10. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
11. Study rationale and design of the CIMT trial: The Copenhagen Insulin and Metformin Therapy Trial
12. Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy—a prospective follow-up study
13. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes
14. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
15. CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy
16. Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
17. Aldosterone synthase (CYP11B2) −344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients
18. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?
19. Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment
20. Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients
21. Birth weight – a risk factor for progression in diabetic nephropathy?
22. Short Stature and Diabetic Nephropathy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.